An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica The peptide problem: Hype is outrunning the evidence FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and Is Your Peptide Store Website FDA Aligned? onPoint Studio Web Design and Development Services